vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $27.5M, roughly 1.5× Sanara MedTech Inc.). Sanara MedTech Inc. runs the higher net margin — -5.9% vs -17.9%, a 12.1% gap on every dollar of revenue. On growth, Sanara MedTech Inc. posted the faster year-over-year revenue change (4.6% vs -23.2%). Sanara MedTech Inc. produced more free cash flow last quarter ($3.9M vs $-10.8M). Over the past eight quarters, Sanara MedTech Inc.'s revenue compounded faster (21.8% CAGR vs -27.2%).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
CMBM vs SMTI — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $27.5M |
| Net Profit | $-7.2M | $-1.6M |
| Gross Margin | 36.6% | 93.2% |
| Operating Margin | -28.4% | 23.5% |
| Net Margin | -17.9% | -5.9% |
| Revenue YoY | -23.2% | 4.6% |
| Net Profit YoY | 71.0% | 5.3% |
| EPS (diluted) | $-0.26 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $27.5M | ||
| Q3 25 | — | $26.3M | ||
| Q2 25 | — | $25.8M | ||
| Q1 25 | — | $23.4M | ||
| Q4 24 | $40.3M | $26.3M | ||
| Q3 24 | $44.7M | $21.7M | ||
| Q2 24 | $45.2M | $20.2M | ||
| Q1 24 | $47.1M | $18.5M |
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $-30.4M | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $-7.2M | $-1.7M | ||
| Q3 24 | $-34.5M | $-2.9M | ||
| Q2 24 | $-14.2M | $-3.5M | ||
| Q1 24 | $-18.4M | $-1.8M |
| Q4 25 | — | 93.2% | ||
| Q3 25 | — | 92.9% | ||
| Q2 25 | — | 92.5% | ||
| Q1 25 | — | 92.2% | ||
| Q4 24 | 36.6% | 91.4% | ||
| Q3 24 | 43.6% | 90.8% | ||
| Q2 24 | 32.5% | 90.0% | ||
| Q1 24 | 29.8% | 89.8% |
| Q4 25 | — | 23.5% | ||
| Q3 25 | — | 11.2% | ||
| Q2 25 | — | -0.1% | ||
| Q1 25 | — | -8.9% | ||
| Q4 24 | -28.4% | 18.6% | ||
| Q3 24 | -69.6% | 3.6% | ||
| Q2 24 | -27.2% | -14.3% | ||
| Q1 24 | -33.1% | -8.3% |
| Q4 25 | — | -5.9% | ||
| Q3 25 | — | -115.5% | ||
| Q2 25 | — | -7.8% | ||
| Q1 25 | — | -15.1% | ||
| Q4 24 | -17.9% | -6.5% | ||
| Q3 24 | -77.3% | -13.2% | ||
| Q2 24 | -31.5% | -17.4% | ||
| Q1 24 | -39.2% | -9.5% |
| Q4 25 | — | $-0.32 | ||
| Q3 25 | — | $-3.40 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.41 | ||
| Q4 24 | $-0.26 | $-0.18 | ||
| Q3 24 | $-1.22 | $-0.34 | ||
| Q2 24 | $-0.51 | $-0.41 | ||
| Q1 24 | $-0.66 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $16.6M |
| Total DebtLower is stronger | $67.6M | $46.0M |
| Stockholders' EquityBook value | $-3.2M | $5.9M |
| Total Assets | $173.7M | $72.9M |
| Debt / EquityLower = less leverage | — | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.6M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | — | $15.9M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $2.8M |
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | $67.6M | $30.7M | ||
| Q3 24 | $67.6M | $30.1M | ||
| Q2 24 | $68.9M | $14.4M | ||
| Q1 24 | $63.8M | $9.7M |
| Q4 25 | — | $5.9M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | — | $35.4M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | $-3.2M | $39.4M | ||
| Q3 24 | $1.9M | $39.8M | ||
| Q2 24 | $34.1M | $41.7M | ||
| Q1 24 | $45.0M | $43.3M |
| Q4 25 | — | $72.9M | ||
| Q3 25 | — | $71.1M | ||
| Q2 25 | — | $98.8M | ||
| Q1 25 | — | $96.4M | ||
| Q4 24 | $173.7M | $88.1M | ||
| Q3 24 | $194.3M | $88.5M | ||
| Q2 24 | $221.1M | $73.4M | ||
| Q1 24 | $219.8M | $70.9M |
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | 36.12× | 0.76× | ||
| Q2 24 | 2.02× | 0.34× | ||
| Q1 24 | 1.42× | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $3.9M |
| Free Cash FlowOCF − Capex | $-10.8M | $3.9M |
| FCF MarginFCF / Revenue | -26.8% | 14.0% |
| Capex IntensityCapex / Revenue | 1.1% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.9M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $-2.0M | ||
| Q4 24 | $-10.4M | $932.0K | ||
| Q3 24 | $8.9M | $2.1M | ||
| Q2 24 | $2.4M | $-1.4M | ||
| Q1 24 | $-15.9M | $-1.6M |
| Q4 25 | — | $3.9M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | — | $902.7K | ||
| Q1 25 | — | $-3.7M | ||
| Q4 24 | $-10.8M | $859.9K | ||
| Q3 24 | $6.8M | $2.0M | ||
| Q2 24 | $87.0K | $-1.5M | ||
| Q1 24 | $-17.4M | $-1.7M |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | -15.9% | ||
| Q4 24 | -26.8% | 3.3% | ||
| Q3 24 | 15.2% | 9.4% | ||
| Q2 24 | 0.2% | -7.3% | ||
| Q1 24 | -37.0% | -9.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | 1.1% | 0.3% | ||
| Q3 24 | 4.8% | 0.0% | ||
| Q2 24 | 5.1% | 0.3% | ||
| Q1 24 | 3.3% | 0.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
